This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Pizzolo, G., Chilosi, M., Vinante, F. et al. Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. Br J Cancer 55, 427–428 (1987). https://doi.org/10.1038/bjc.1987.83
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.83
This article is cited by
-
Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy
Annals of Hematology (2019)
-
High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma
Annals of Hematology (2017)
-
Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes
BMC Gastroenterology (2012)
-
The clinicopathological significance of preoperative serum-soluble interleukin-2 receptor concentrations in operable non-small-cell lung cancer patients
Annals of Surgical Oncology (2000)
-
Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1α, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies
Cell Biophysics (1995)